|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Sep―17 |
Characterization of QuantiFERON Severe Acute Respiratory Syndrome Coronavirus 2 and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid and S1 Spike Protein Antibodies in Vaccinated and Unvaccinated Coronavirus Disease 2019 Patients |
Esmaeil Mortaz, Neda Dalil Roofchayee, Hamidreza Jamaati, Payam Tabarsi, Shahrzad Ahmadi, Heshmat Shahi, et al. (+4) Mohammad Varahram, Kimia Behzad Mogadam, Mohammad M. Sajadi, Ian M. Adcock |
2 |
[GO] |
2024―Sep―17 |
Multidrug-resistant Organism and Antibiotic Sensitivity Patterns, before, during, and after the Coronavirus Disease 2019 Pandemic in the Dr. M. Djamil Central General Hospital, Padang, Indonesia |
Fadrian Fadrian, Linosefa Linosefa, Armen Ahmad, Rohayat Bilmahdi Simanjuntak, Rohadatul Aisy |
3 |
[GO] |
2024―Sep―17 |
Association of Serum Biomarkers with C-X-C Motif Chemokine Receptor 3 Gene Polymorphism and Severity of Coronavirus-2019 Infection |
Usha Sachidananda Adiga, Sachidananda Narasimha Adiga, Tirthal Rathnakar Rai |
4 |
[GO] |
2024―Jul―05 |
Case Series of Long COVID-19 among Patients with Good’s Syndrome |
|
5 |
[GO] |
2024―Jul―05 |
Investigating the Effect of Polymacrocycles on the Specific Absorption of the COVID-19 Virus in Surgical, Three-layer, and Fabric Masks |
|
6 |
[GO] |
2024―Jul―05 |
Effect of Cold Atmospheric Plasma on Apoptosis of Lung Epithelial Cells Infected with Coronavirus Disease 2019 |
|
7 |
[GO] |
2024―Jun―18 |
Correlation between Cardiac Output and Disease Severity in Intubated COVID-19 Patients: Insights from Ultrasonic Cardiac Output Monitoring in Intensive Care Unit Settings |
Seyed Mohammadreza Hashemian, Batoul Khoundabi, Hamidreza Jamaati, Makan Sadr, Hassan Safdari, Farzad Rashidi, et al. (+4) Mohammad Varahram, Navid Noraee, Ashkan Bahrami, Reza Eshraghi |
8 |
[GO] |
2024―Jun―18 |
Diagnostic Precision of Molecular Testing for Severe Acute Respiratory Syndrome Coronavirus 2 versus Chest Computer Tomography |
Aravapalli Venkata Raghavendra Rao, Reena Rajan, Mathavi Suresh Kumar |
9 |
[GO] |
2024―Jun―18 |
Comparative Analysis of Pooling Methods for SARS-CoV-2 Real-time Polymerase Chain Reaction Testing |
Vishwajit M. Paikrao, Umesh S. Hassani, Neena V. Nagdeo |
10 |
[GO] |
2024―Mar―25 |
COVID-19 Second Wave with Mucormycosis, a Deadly Combination: A Systemic Review |
Neetu Jain, Seema Bhadauria |
11 |
[GO] |
2024―Jan―02 |
Stimulator of Interferon Genes, the Missing Link in the Pathogenesis of COVID-19 |
Mitra Rezaei, Alireza Mirahmadi, Niloufar Bineshfar, Majid Marjani, Davood Mansouri |
12 |
[GO] |
2024―Jan―02 |
Inter-host Genetic Variability of Severe Acute Respiratory Syndrome Coronavirus 2 and its Implication in Biomedicine: A Bioinformatics Approach |
Víctor Eduardo Rojas-Pérez, Eduardo René Parra Villegas |
13 |
[GO] |
2023―Aug―09 |
Tamoxifen from chemotherapy to antiviral drug: Possible activity against COVID-19 |
FalahHasan Obayes AL-Khikani, HudaAli Salman Almosawey, RaghdahMaytham Hameed, YounusJasim Abdullah, MohanadKadhim Mirdan Al-Ibraheemi, AtyafAli Al-Asadi |
14 |
[GO] |
2023―Aug―09 |
Potential therapeutic effects of pentoxifylline against COVID-19 |
Farzaneh Dastan, Atefeh Abedini, Faezeh Feizabadi, Arda Kiani |
15 |
[GO] |
2023―Aug―09 |
End-of-life guidelines: Iran confronts COVID-19 |
SeyedMohammad Reza Hashemian, James Miller |
16 |
[GO] |
2023―Aug―09 |
Investigation of the hypothesis of biofilm formation in coronavirus (COVID-19) |
Parissa Farnia, Saeid Besharati, Poopak Farnia, Jalaledin Ghanavi, AliAkbar Velayati |
17 |
[GO] |
2023―Aug―09 |
Supplementary medicines and antioxidants in viral infections: A review of proposed effects for COVID-19 |
Anmar Al-Taie, ArueyinghoOritsetimeyin Victoria |
18 |
[GO] |
2023―Aug―09 |
The effectiveness of cold atmospheric plasma by inhaling anesthetic mask or through bronchoscopy against COVID-19 |
Jalaledin Ghanavi, Poopak Farnia, Hamidreza Ghomi |
19 |
[GO] |
2023―Aug―09 |
Cytokine storm in COVID-19 and the treatment simulacrum |
SeyedMohammad Reza Hashemian, Anita Karimi |
20 |
[GO] |
2023―Aug―09 |
Modified VGG deep-learning architecture for COVID-19 classification using chest radiography images |
R Anand, V Sowmya, Vijaykrishna Menon, A Gopalakrishnan, KP Soman |
21 |
[GO] |
2023―Aug―09 |
Specially inactivation of SARS-CoV-2 (COVID-19) on surgical or homemade masks and medical clothing: Innovative solution attachment |
Jalaledin Ghanavi, Rozhina Ghanavi, SeyedAlireza Nadji, Poopak Farnia |
22 |
[GO] |
2023―Aug―09 |
Descriptive review of epidemiological geographic mapping of coronavirus disease 2019 (COVID-19) on the internet |
BrianChanda Chiluba, Gugulethu Dube |
23 |
[GO] |
2023―Aug―09 |
A multipronged strategy operationalized to combat the COVID-19 pandemic in India |
Bijit Biswas, Vikas Bhatia, Neeraj Agarwal |
24 |
[GO] |
2023―Aug―09 |
Evaluation of mobile phone-based tele-monitoring of cystic fibrosis patients during the COVID-19 pandemic: A 3-year experience in Iran |
Maryam Hassanzad, Ali Valinejadi, Lida Fadaizadeh, SeyedMohammad Jafar Taheri, Poopak Farnia, Nima Hassanzad, et al. (+10) HosseinAli Ghaffaripoor, Noushin Baghaei, Mahdieh Arian, Masoumeh Ansari, Zahra Daneshmandi, ElhamSadat Sadati, Parisa Honarpisheh, Mahsa Rekabi, Leila Mohammadpour, AliAkbar Velayati |
25 |
[GO] |
2023―Aug―09 |
Evidence for SARS-CoV-2 circulating among stray dogs and cats: Should we worry about our pets during the COVID-19 Pandemic? |
Parissa Farnia, Jafar Aghajani, Poopak Farnia, Saman Ayoubi, Jalaledin Ghanavi, SeyedAlireza Nadji, et al. (+2) Sven Hoffner, AliAkbar Velayati |
26 |
[GO] |
2023―Aug―09 |
Serum levels of interleukin-6, ferritin, C-reactive protein, lactate dehydrogenase, D-dimer, and count of lymphocytes and neutrophils in COVID-19 patients: Its correlation to the disease severity |
YounusJasim Abdullah, AliSaad Kadhim |
27 |
[GO] |
2023―Aug―09 |
Lifesaving combined treatment in a rapidly progressive COVID-19 pneumonia case with extensive lung involvement |
SeyedMohammad Reza Hashemian, Razieh Farrokhi, Payam Tabarsi, Hamidreza Jamaati, AliAkbar Velayati |
28 |
[GO] |
2023―Aug―09 |
The importance of genomic changes of SARS-CoV-2 and its comparison with Iranian-reported COVID-19 sequencing; Whether each country has to design its treatment and vaccine production |
Parissa Farnia, AliAkbar Velayati, Saeid Besharati, Poopak Farnia, Jalaledin Ghanavi |
29 |
[GO] |
2023―Aug―09 |
Surveillance 2019 novel coronavirus (COVID-19) spreading: Is a terrifying pandemic outbreak is soon? |
FalahHasan Obayes AL-Khikani |
30 |
[GO] |
2023―Aug―09 |
Computer-assisted multi-epitopes T-cell subunit Covid-19 vaccine design |
AbdulwahidAbaukaka Yahaya, Salihu Sanusi, FatimaUmar Malo |
31 |
[GO] |
2023―Aug―09 |
COVID-19-Related severe heterogeneous acute respiratory distress syndrome: A therapeutic challenge |
Lida Fadaizadeh, Hamidreza Jamaati, Batoul Khoundabi, SeyedMohammad Hashemian, Fatemeh Monjazabi, Alireza Jahangirifard, et al. (+15) MohammadTaghi Beigmohammadi, Behrooz Farzanegan, Seyedpouzhia Shojaei, Payam Tabarsi, Farzaneh Dastan, SeyedAli Reza Nadji, MihanPourabdollah Toutkaboni, Majid Malekmohammad, Abdolreza Mohamadnia, Esmail Mortaz, Maryam Mirenayat, Fatemeh Yassari, Jalal Heshmatnia, Alireza Eslaminejad, AliAkbar Velayati |
32 |
[GO] |
2023―Aug―09 |
The efficacy and safety of sitagliptin administration in patients with Covid-19: A randomized clinical trial |
Atefeh Abedini, Ahad Zare, NahidEtemadi Toudeshki, ZahraAmeri Ahmad, Farzaneh Dastan, Elham Oveili, Arda Kiani |
33 |
[GO] |
2023―Aug―09 |
Outcome of COVID-19: A trend analysis |
Madhavaprasad Dasari, Kavitha Chandu |
34 |
[GO] |
2023―Aug―09 |
Renin-Angiotensin system and fibrinolytic pathway in COVID-19: One-way skepticism |
HayderMutter Al-Kuraishy, NawarRaad Hussien, MarwaSalih Al-Naimi, AliKadhem Al-Buhadily, AliIsmail Al-Gareeb, Claire Lungnier |
35 |
[GO] |
2023―Aug―09 |
Is ivermectin-Azithromycin combination the next step for COVID-19? |
HayderMutter Al-Kuraishy, NawarRaad Hussien, MarwaSalih Al-Naimi, AliKadhem Al-Buhadily, AliIsmail Al-Gareeb, Claire Lungnier |
36 |
[GO] |
2023―Aug―09 |
A comparative study between the severe acute respiratory syndrome-Coronavirus-2, severe acute respiratory syndrome coronavirus, and the middle east respiratory syndrome coronavirus |
Rashed Noor, SyedAbdullah Ibn Asaduzzaman, Amayna Zakaria, IloraShabnam Kheya, Nazmul Fahad, YusraBinte Sikandar |
37 |
[GO] |
2023―Aug―09 |
Can animals like bats, pangolins, and ticks would be considered as long-term reservoirs of severe acute respiratory syndrome coronavirus 2 |
Parissa Farnia, Jafar Aghajani, Saman Ayoubi, Poopak Farnia, Jalaledin Ghanavi, AliAkbar Velayati |
38 |
[GO] |
2023―Aug―09 |
Impact of Proinflammatory Cytokines: (Interleukin 6, Interleukin 1α, and Interleukin 1β) on Biochemical Parameters in Severe Acute Respiratory Syndrome Coronavirus 2 Patients in Iraq |
IsmaelRaheem Al-Muhana, MohanadMohsin Ahmed, IshaqRaheem Al-Muhana, BaraaAkeel AL-Hasan |
39 |
[GO] |
2023―Aug―09 |
Will the current coronavirus disease 2019 affect progress in the attainment of sustainable development goals in Africa? |
BrianChanda Chiluba, Fredrick Chitangala, Gugulethu Dube |
40 |
[GO] |
2023―Aug―09 |
Cycle threshold value and coronavirus disease 2019 clinical type among smokers and nonsmokers reveal no significant association despite clinical type shows smokers are at high risk: A retrospective study |
Varshiesh Raina, AhmarJavid Azad, SuboorAhmad Naik, AltafAhmad Malik |
41 |
[GO] |
2023―Aug―09 |
Influence of Coronavirus Disease 2019 on human biological timekeeping |
Manikantan Pappuswamy, Aditi Chaudhary, KuppusamyAlagesan Paari, Shalie Malik, Arun Meyyazhagan, HaripriyaKuchi Bhotla, et al. (+2) Balamuralikrishnan Balasubramanian, VijayaAnand Arumugam |
42 |
[GO] |
2023―Aug―09 |
Assessment of serum levels of homocysteine, Ang 1-7, and plasminogen activator Inhibitor-1 protein in samples of coronavirus disease 2019 patients in Iraq |
GhazwanFaisal Hussein, AliHmood Al-Saadi |
43 |
[GO] |
2023―Aug―09 |
Mini-review on recent update on coronavirus disease 2019: Clinical outcome and largest pharmaceutical companies |
Pooja Shivappa, Ashfaque Hoosain, PadmaG.M. Rao |
44 |
[GO] |
2023―Aug―09 |
In vitro study of the spectrum antiviral activity of aliphatic acid toward the prototype coronavirus strain |
Marina Sidorenko, IrynaV Dziublyk, SerhiiO Soloviov, OlenaP Trokhimenko, OleksandrYa Dziublyk, MykhailoP Smetiukh, et al. (+4) OlehK Yakovenko, Volodymyr Vasylenko, Saulius Mickevicius, MykolaI Gumeniuk |
45 |
[GO] |
2023―Aug―09 |
Study on the prevalence of severe acute respiratory syndrome Coronavirus-2 in Theni District, Tamil Nadu |
S Lallitha, R Gopinath, R Gopinathan, R Jegatheesh, A Dhanasezhiyan, M Amudhan |
46 |
[GO] |
2023―Aug―09 |
Coronavirus: A potential threat for dental practitioners |
BhupenderSingh Negi, RH Shilpa, SamarjeetJ Pattnaik, Pooja Pani, Nishant Pani |
47 |
[GO] |
2023―Aug―09 |
Can Hesperidin be the Key to the Treatment of Severe Acute Respiratory Syndrome COV-2? |
Atefeh Abedini, SeyedBashir Mirtajani, Mani Karimzadeh, Alireza Jahangirifard, Arda Kiani |
48 |
[GO] |
2023―Mar―14 |
An observational comparative study of clinicoepidemiological profile of COVID-19 patients admitted in the tertiary care hospital during first and second wave on pandemic |
SurendraBabu Darivemula, Chennakesavulu Dara, Triveni Sagar, Sudha Bala, Venkatesham Animalla |
49 |
[GO] |
2023―Mar―14 |
Effectiveness and adverse effects of astrazeneca and pfizer COVID-19 vaccines among medical students in Oman: A comparative study |
MohanBilikallahalli Sannathimmappa, Vinod Nambiar, Rajeev Aravindakshan, MuqeetFauzan Baig, AhmedKifah Hassan, MaryamSaud Mohammed Al-Balushi |
50 |
[GO] |
2023―Mar―14 |
Cost-Utility analysis for rapid severe acute respiratory syndrome-coronavirus-2 antigen detection assay in comparison versus real-time reverse transcription-polymerase chain reaction assay for laboratory diagnosis of coronavirus disease -2019 |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
51 |
[GO] |
2023―Mar―14 |
The consequences of severe acute respiratory syndrome coronavirus-2 on acute kidney injury among iraqi patients |
HamzahAbdulrahman Salman, ZahraaFaris Al-Khero, Zahra'aAbd Al-Aziz Yousif, AllaaHatim Thanoon |
52 |
[GO] |
2022―Dec―14 |
Modified intelligent magnetic nanoparticles as a treatment for severe acute respiratory syndrome coronavirus type 2 In Silico |
Reza Aghanouri, Arefeh Khodaee, Nima Shirmohammadi |
53 |
[GO] |
2022―Dec―14 |
Omicron, a New Variant of Severe Acute Respiratory Syndrome Coronavirus-2 Virus: Global Upsurge, Devastation, and Future Prospect |
Awanish Kumar |
54 |
[GO] |
2022―Oct―06 |
The association of serum creatine phosphokinase levels with severity of lung involvement and hypoxia in patients with COVID-19 |
Atefeh Abedini, Arda Kiani, Fatemehsadat Rahimi, Siamak Afaghi, Marjan Mehrparvar, Sasan Tavana, Mohammad Varharam |
55 |
[GO] |
2022―Oct―06 |
Relationship between the hematological indices and COVID-19 |
Abdalkhalig Elkhider, NoonAhmed Khalil, BabikerSaad Almugadam |
56 |
[GO] |
2022―Oct―06 |
Evaluation of immunoglobulin G level among subjects vaccinated with different types of COVID-19 vaccines in the karbala population, Iraq |
RawaqTaleb Hassan, SuhadH Mohammed |
57 |
[GO] |
2022―Jul―25 |
A review on COVID-19 vaccinations |
Ketan Garg, Dipesh Talwar, SamikshaNaresh Mahajan, Sana Karim, Kesar Prajapati, Savan Patel, Bhawna Garg |
58 |
[GO] |
2022―Jul―25 |
Recent insights of SARS-CoV-2 potential inhibitors |
VinayKumar Singh, Abhishek Srivastava, Mohd Faheem |
59 |
[GO] |
2021―Dec―14 |
Formulation of new intelligent nanoparticle inhibited h1n1 influenza subtype and SARS coronavirus type 2 (COVID-19) in vitro |
Reza Aghanouri, Nima Shirmohammadi, Arefeh Khodaee, Maryam Rahimi, Marzieh Vanayi |
60 |
[GO] |
2021―Dec―14 |
Plant-based vaccines: Potentiality against severe acute respiratory syndrome coronavirus 2 |
Rabindranath Majumder, Pramita Sharma, Himel Mondal, Shaikat Mondal |
61 |
[GO] |
2021―Sep―06 |
2-Deoxy-D-glucose as an armament against COVID-19: The key to return to normality? |
TarunKumar Suvvari, ManiKruthika Mantha, AnnaChiara Corriero |
62 |
[GO] |
2021―Jun―15 |
Disinfectants in the arena of COVID-19 |
Kamal Shah, Sumit Chhabra, NagendraSingh Chauhan |
63 |
[GO] |
2021―Jun―15 |
Acute respiratory distress syndrome and pneumothorax in COVID-19 patients |
SeyedMohammad Reza Hashemian, Navid Shafigh, Raziyeh Erfani, Batoul Khoundabi, James Miller |
64 |
[GO] |
2021―Jun―15 |
Vaccine in response to COVID-19: Recent developments, challenges, and a way out |
Sameer Quazi |
65 |
[GO] |
2021―Jun―15 |
A review on Coronavirus Disease and potentially active drugs targeting Coronavirus |
Kamal Shah, Tarawanti Verma, Manish Sinha, Bansal Nitin, ShyamRaj Yadav, NagendraSingh Chauhan |
66 |
[GO] |
2021―Jun―15 |
Prevalence of severe acute respiratory syndrome Coronavirus-2 among the young people and association between diabetes, hypertension, and severe acute respiratory syndrome Coronavirus-2 |
Aklima Akter, Nafisa Tabassum, Arifur Rahman |
67 |
[GO] |
2021―Jan―14 |
In Silico modeling and docking study of potential helicase (nonstructural proteins) inhibitors of novel coronavirus 2019 (severe acute respiratory syndrome coronavirus 2) |
Raghunath Satpathy |
68 |
[GO] |
2021―Jan―14 |
Saliva as an alternate specimen source for the diagnosis of coronavirus disease 2019 in symptomatic patients using cepheid xpert xpress SARS-CoV-2 |
Maya Habous, RaniaMedhat Seliem, Laila AlDabal, Firas Al-Najjar, Maimona Elimam, Meera Jainmboo, et al. (+3) Bayan Abdalla, Zahra Abdullahi, Ayesha Nasser |
69 |
[GO] |
2021―Jan―14 |
FNCas9 editor-linked uniform detection assay: An innovative COVID-19 sleuth |
TarunKumar Suvvari, MD Nawaz, ManiKruthika Mantha |
70 |
[GO] |
2021―Jan―14 |
Diagnostic errors of coronavirus infection: Role of fluorodeoxyglucose positron emission tomography/computed tomography scan |
Abtin Doroudinia, Elinaz Hosseinzadeh, IsaNeshandar Asli, MehrdadBakhshayesh Karam, Payam Mehrian |
71 |
[GO] |
2020―Sep―11 |
Macrolides and COVID-19: An optimum premise |
HayderM Al-Kuraishy, MarwaS Al-Naimi, ClaireM Lungnier, AliI Al-Gareeb |
72 |
[GO] |
2020―Sep―11 |
Coronavirus disease 2019 pandemic: Envisaging capacity building in the field of research to accomplish effective control |
SaurabhRamBihariLal Shrivastava, PrateekSaurabh Shrivastava |